ACE antibody

Este producto es parte de ACE - Angiotensin I Converting Enzyme
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
ACE antibody
category
Primary Antibodies
provider
FineTest
reference
FNab00080
tested applications
ELISA, WB

Description

Converts angiotensin I to angiotensin II by release of the terminal His-Leu, this results in an increase of the vasoconstrictor activity of angiotensin. Also able to inactivate bradykinin, a potent vasodilator. Has also a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety.

Documents del producto

Instrucciones
Descargar
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
angiotensin I converting enzyme(peptidyl-dipeptidase A) 1 (ACE)
Host
Rabbit
Reactivity
Human, Mouse
Recommended Dilution
WB: 1:500-1:5000; IP: 1:500-1:5000
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
170 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, WB
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
P12821
Gene ID
1636
Alias
ACE1,CD143,DCP,DCP1,ICH,MVCD3
Background
Antibody anti-ACE
Status
RUO
Note
Mol. Weight 170 kDa

Descripción

Angiotensin converting enzyme (ACE) is a pivotal enzyme in the Renin-Angiotensin-Aldosterone System (RAAS), a key regulator of blood pressure and fluid balance in the body. ACE plays a crucial role in converting angiotensin I to angiotensin II, a potent vasoconstrictor, thereby increasing blood pressure. ACE inhibitors are commonly prescribed medications that block this conversion, leading to vasodilation and reduced blood pressure. Apart from its role in blood pressure regulation, ACE also has functions in the metabolism of other peptides, including bradykinin. Dysregulation of ACE activity is associated with various cardiovascular diseases, such as hypertension, heart failure, and myocardial infarction. ACE inhibitors are widely used in the management of hypertension, heart failure, and certain kidney diseases. ACE gene polymorphisms have been linked to differences in individual responses to ACE inhibitors and susceptibility to cardiovascular diseases. Understanding the role of ACE has led to the development of novel therapeutic strategies targeting the RAAS for the treatment of cardiovascular disorders.

Related Products

EGP0001

Guinea pig ACE (Angiotensin I Converting Enzyme) ELISA Kit

Ver Producto
EH0026

Human ACE (Angiotensin I Converting Enzyme) ELISA Kit

Ver Producto
EM0011

Mouse ACE (Angiotensin I Converting Enzyme) ELISA Kit

Ver Producto